September 15, 2016 by Lydia Adams
Altor Bioscience is a clinical-stage biopharmaceutical company using cytokine technology to develop immunotherapies for the treatment of cancer and viral infections. Altor is dedicated to researching every aspect of cancer and viral infections by utilizing their STAR and IL-15 Superagonist platforms.
Altor Bioscience came to us with a goal to reach a wider range of audiences. Their website needed to speak to viewers with varying levels of knowledge on curing cancer and viral infections. We wanted to articulate Altor’s mission to audiences like scientists, investors, and the general public.
We accomplished this goal by creating a lead-in for each target on the home page. “Our Science” for the scientists, “Pipeline” for patients looking for answers, and “News” for investors to understand that Altor means business. We also simplified the site, paying close attention to strong imagery and content that will appeal to each target audience.
In addition, we wanted to showcase Altor Bioscience’s participation in The Cancer Moonshot 2020 Program. This collaboration brings researchers together to provide necessary tools for furthering technology for finding the cure for cancer.
Working with the Altor Bioscience team, we were able to produce a site that communicates the Altor technology and solutions to any viewer.
This was the site before:
And the after here: